National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant adenovirus-p53 SCH-58500
A genetically-engineered adenovirus that contains the gene that encodes the human tumor-suppressor protein p53 with potential antineoplastic activity. Recombinant adenovirus-p53 SCH-58500 delivers p53 into tumor cells, which may result in p53-mediated cell cycle arrest and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:rAd/p53
Code name:SCH-58500



Previous:Recentin, recombinant 70-kD heat-shock protein, recombinant adenovirus-hIFN-beta, recombinant adenovirus-interferon SCH 721015, recombinant adenovirus-L523S vaccine
Next:recombinant bispecific single-chain antibody rM28, recombinant CD40-ligand, recombinant dHER2 vaccine, recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov